Literature DB >> 15593260

Cytologic features of renal medullary carcinoma.

Lina Assad1, Erika Resetkova, Victor L Oliveira, Wei Sun, John M Stewart, Ruth L Katz, Nancy P Caraway.   

Abstract

BACKGROUND: Renal medullary carcinoma is a rare tumor that is most common in young black men with sickle cell disease or trait. Patients often present with advanced disease at the time of diagnosis, and their prognosis is poor, even with aggressive therapy. The clinical and pathologic features of renal medullary carcinoma have been described in several articles, but reports describing the cytologic features are rare.
METHODS: In the current report, the authors describe the cytologic features of three cases of renal medullary carcinoma. The patients were young black men with sickle cell trait ages 20 years, 33 years, and 33 years.
RESULTS: All three patients presented with hematuria, flank pain, and a renal mass. The cytologic specimens from all three patients showed primarily cohesive groups of cells with vacuolated cytoplasm that often displaced or indented the nuclei. The nuclei often had irregular membranes, coarse or vesicular chromatin, and prominent nucleoli. Both of the two patients who were tested with fluorescence in situ hybridization were negative for the bcr/abl rearrangement.
CONCLUSIONS: Renal medullary carcinoma should be considered in the differential diagnosis of patients who present with hematuria or a renal mass, especially in young black men with sickle cell disease or trait. Cytologically, renal medullary carcinoma cells appear similar to the cells in high-grade carcinoma. Immunohistochemical studies can be helpful in distinguishing renal medullary carcinoma from other poorly differentiated kidney tumors, except for collecting duct carcinoma. The clinical findings are key to diagnosing renal medullary carcinoma. 2005 American Cancer Society

Entities:  

Mesh:

Year:  2005        PMID: 15593260     DOI: 10.1002/cncr.20764

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.

Authors:  Amishi Y Shah; Jose A Karam; Gabriel G Malouf; Priya Rao; Zita D Lim; Eric Jonasch; Lianchun Xiao; Jianjun Gao; Ulka N Vaishampayan; Daniel Y Heng; Elizabeth R Plimack; Elizabeth A Guancial; Chunkit Fung; Stefanie R Lowas; Pheroze Tamboli; Kanishka Sircar; Surena F Matin; W Kimryn Rathmell; Christopher G Wood; Nizar M Tannir
Journal:  BJU Int       Date:  2016-12-09       Impact factor: 5.588

2.  VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?

Authors:  Nathaniel E Smith; Andrea T Deyrup; Adrian Mariño-Enriquez; Jonathan A Fletcher; Julia A Bridge; Peter B Illei; George J Netto; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

3.  Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.

Authors:  Jacob S Lipkin; Syed M Rizvi; Zoran Gatalica; Nabeel E Sarwani; Sheldon L Holder; Mathew Kaag; Joseph J Drabick; Monika Joshi
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Renal Medullary Carcinoma with an Aggressive Clinical Course: A Case Report and Review of the Literature.

Authors:  Madhumati R Kalavar; Sami Ali; Damoun Safarpour; Saroj Davi Kunnakkat
Journal:  Case Rep Oncol       Date:  2017-01-06

5.  Lung tumor in a young African American patient with sickle trait: Pieces of a puzzle.

Authors:  Mariam Mir; Michelle Parmley; Kyle Molberg; Stacy Hinson; Joel Thibodeaux; Elena Lucas
Journal:  Cytojournal       Date:  2018-08-27       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.